Prudent Man Advisors, LLC Astrazeneca PLC Transaction History
Prudent Man Advisors, LLC
- $263 Million
- Q1 2024
A detailed history of Prudent Man Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Prudent Man Advisors, LLC holds 3,094 shares of AZN stock, worth $237,216. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,094
Previous 3,761
17.73%
Holding current value
$237,216
Previous $253,000
17.39%
% of portfolio
0.08%
Previous 0.1%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,250Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.7 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.77 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.29 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.65 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.32 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $238B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...